You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

J&J Taps Merck Plant in Durham, North Carolina, for COVID-19 Vaccine Production, an Industrial Info Market Brief

default

Industry Segment: Market Brief | Word Count: 92 Words
Attachment: A

Merck's Maurice R. Hillman Center for Vaccine Manufacturing in Durham (Treyburn), NC is on board to help with boosting production of Johnson & Johnson's COVID-19 vaccine. The plant will provide the bulk drug substance (biological active pharmaceutical ingredient) for the drug.

One of two plants designated to help produce the drug, the Durham facility has $800 million in active capital expansion projects.

Subscribe Now! All Fields Required...

Standard Membership - Free